Board Members

Elected 2016

Rebecka Belldegrun, MD, is an investor, entrepreneur, and philanthropist. She is president and CEO of Bellco Capital, an investment firm she founded in 2003 that specializes in life sciences, media, and real estate. She has extensive experience in early-stage biotech investments, drug development, and bringing products to market.

Belldegrun graduated from Sackler School of Medicine at Tel Aviv University and completed her residency in ophthalmology and a postdoctoral fellowship in corneal surgery at the Massachusetts Eye and Ear Infirmary, Harvard Medical School.

Prior to Bellco Capital, Belldegrun founded Intertech Corporation, a New York- and Los Angeles-based real estate company specializing in development, investments, and acquisitions. During her role as president of Intertech, she built a portfolio of hotels and commercial properties in Europe and Israel.

Belldegrun serves on the board of Kronos Bio, a biotechnology company dedicated to research and development of first-in-class cancer therapies based on proprietary technology developed by scientists at MIT. Additionally, she is on the advisory board for the Roy and Diana Vagelos Program in Life Sciences and Management at the University of Pennsylvania and serves on the board of trustees of the Interdisciplinary Center in Israel.

Belldegrun also serves on the boards of First Media, Baby First TV, Breakthrough Properties, and she is a trustee at the Los Angeles County Museum of Art (LACMA). Previously, Belldegrun served as chair of the board of trustees at the Brentwood School in Los Angeles, the University of Pennsylvania Parents Leadership Committee, as member of the board of advisors to the RAND Corporation, and the USC Center on Public Diplomacy.                           

Belldegrun's husband, Dr. Arie Belldegrun, is the executive chairman and co-founder of Allogene. He currently serves as chairman of Two River Group, UroGen Pharma, and Kronos Bio. He is also co-chairman of Breakthrough Properties and director of the Institute of Urologic Oncology at the David Geffen School of Medicine. Drs. Belldegrun reside in Los Angeles and have four children.

Standing Committees: Executive; Governance and Nominating, chair